Summary
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called antigens). The technology behind the generation of monoclonal antibodies was discovered in 1972 by Csar Milstein and Georges Kohler scientists at the Roche-funded Basel Institute for Immunology who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
The global Monoclonal Mouse Antibody market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
IgM
IgG
IgA
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Therapeutic
Research
Diagnostic
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Monoclonal Mouse Antibody of Research
1.1.1 Definition
1.1.2 Specifications of Monoclonal Mouse Antibody
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 IgM Overview
1.2.1.2 IgG Overview
1.2.1.3 IgA Overview
1.2.1.4 Others Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Therapeutic
1.3.1.2 Research
1.3.1.3 Diagnostic
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 IgM Market Size 2018-2023
3.1.1.1 Global IgM Market Size and Growth Rate 2018-2023
3.1.1.2 Global IgM Market Size by Region 2018-2023
3.1.2 IgG Market Size 2018-2023
3.1.2.1 Global IgG Market Size and Growth Rate 2018-2023
3.1.2.2 Global IgG Market Size by Region 2018-2023
3.1.3 IgA Market Size 2018-2023
3.1.3.1 Global IgA Market Size and Growth Rate 2018-2023
3.1.3.2 Global IgA Market Size by Region 2018-2023
3.1.4 Others Market Size 2018-2023
3.1.4.1 Global Others Market Size and Growth Rate 2018-2023
3.1.4.2 Global Others Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 IgM Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global IgM Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global IgM Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 IgG Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global IgG Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global IgG Market Estimates and Forecasts by Region 2024E-2030F
3.2.3 IgA Market Estimates and Forecasts 2024E-2030F
3.2.3.1 Global IgA Market Forecasts and Growth Rate 2024E-2030F
3.2.3.2 Global IgA Market Estimates and Forecasts by Region 2024E-2030F
3.2.4 Others Market Estimates and Forecasts 2024E-2030F
3.2.4.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
3.2.4.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Therapeutic Market Size 2018-2023
4.1.1.1 Global Therapeutic Market Size and Growth Rate 2018-2023
4.1.1.2 Global Therapeutic Market Size by Region 2018-2023
4.1.2 Research Market Size 2018-2023
4.1.2.1 Global Research Market Size and Growth Rate 2018-2023
4.1.2.2 Global Research Market Size by Region 2018-2023
4.1.3 Diagnostic Market Size 2018-2023
4.1.3.1 Global Diagnostic Market Size and Growth Rate 2018-2023
4.1.3.2 Global Diagnostic Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Therapeutic Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Therapeutic Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Therapeutic Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Research Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Research Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Research Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Diagnostic Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Diagnostic Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Diagnostic Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Monoclonal Mouse Antibody Market Competition
7.1.1 Global Monoclonal Mouse Antibody Market by Companies
7.1.2 Global Monoclonal Mouse Antibody Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Roche
8.1.1 Roche Company Profile
8.1.2 Roche Product Portfolio
8.1.3 Roche Business Performance
8.1.4 Roche Development Overview
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Company Profile
8.2.2 Johnson & Johnson Product Portfolio
8.2.3 Johnson & Johnson Business Performance
8.2.4 Johnson & Johnson Development Overview
8.3 Merck
8.3.1 Merck Company Profile
8.3.2 Merck Product Portfolio
8.3.3 Merck Business Performance
8.3.4 Merck Development Overview
8.4 Novartis
8.4.1 Novartis Company Profile
8.4.2 Novartis Product Portfolio
8.4.3 Novartis Business Performance
8.4.4 Novartis Development Overview
8.5 AbbVie
8.5.1 AbbVie Company Profile
8.5.2 AbbVie Product Portfolio
8.5.3 AbbVie Business Performance
8.5.4 AbbVie Development Overview
8.6 Amgen
8.6.1 Amgen Company Profile
8.6.2 Amgen Product Portfolio
8.6.3 Amgen Business Performance
8.6.4 Amgen Development Overview
8.7 Pfizer
8.7.1 Pfizer Company Profile
8.7.2 Pfizer Product Portfolio
8.7.3 Pfizer Business Performance
8.7.4 Pfizer Development Overview
8.8 Bayer
8.8.1 Bayer Company Profile
8.8.2 Bayer Product Portfolio
8.8.3 Bayer Business Performance
8.8.4 Bayer Development Overview
8.9 Lilly
8.9.1 Lilly Company Profile
8.9.2 Lilly Product Portfolio
8.9.3 Lilly Business Performance
8.9.4 Lilly Development Overview
8.10 Bristol-Myers Squibb
8.10.1 Bristol-Myers Squibb Company Profile
8.10.2 Bristol-Myers Squibb Product Portfolio
8.10.3 Bristol-Myers Squibb Business Performance
8.10.4 Bristol-Myers Squibb Development Overview
8.11 GlaxoSmithKline
8.11.1 GlaxoSmithKline Company Profile
8.11.2 GlaxoSmithKline Product Portfolio
8.11.3 GlaxoSmithKline Business Performance
8.11.4 GlaxoSmithKline Development Overview
8.12 Biogen
8.12.1 Biogen Company Profile
8.12.2 Biogen Product Portfolio
8.12.3 Biogen Business Performance
8.12.4 Biogen Development Overview
8.13 AstraZeneca
8.13.1 AstraZeneca Company Profile
8.13.2 AstraZeneca Product Portfolio
8.13.3 AstraZeneca Business Performance
8.13.4 AstraZeneca Development Overview
8.14 Sanofi
8.14.1 Sanofi Company Profile
8.14.2 Sanofi Product Portfolio
8.14.3 Sanofi Business Performance
8.14.4 Sanofi Development Overview
8.15 Alexion Pharmaceuticals
8.15.1 Alexion Pharmaceuticals Company Profile
8.15.2 Alexion Pharmaceuticals Product Portfolio
8.15.3 Alexion Pharmaceuticals Business Performance
8.15.4 Alexion Pharmaceuticals Development Overview
8.16 Seattle Genetics
8.16.1 Seattle Genetics Company Profile
8.16.2 Seattle Genetics Product Portfolio
8.16.3 Seattle Genetics Business Performance
8.16.4 Seattle Genetics Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION